GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invizyne Technologies Inc (NAS:IZTC) » Definitions » Total Equity

IZTC (Invizyne Technologies) Total Equity : $-3.60 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Invizyne Technologies Total Equity?

Invizyne Technologies's total equity for the quarter that ended in Sep. 2024 was $-3.60 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Invizyne Technologies Total Equity Historical Data

The historical data trend for Invizyne Technologies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invizyne Technologies Total Equity Chart

Invizyne Technologies Annual Data
Trend Dec21 Dec22 Dec23
Total Equity
1.20 1.37 -0.38

Invizyne Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 -0.38 -1.25 -2.26 -3.60

Invizyne Technologies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Invizyne Technologies's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=3.559-3.943
=-0.38

Invizyne Technologies's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=3.56-7.162
=-3.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invizyne Technologies Total Equity Related Terms

Thank you for viewing the detailed overview of Invizyne Technologies's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Invizyne Technologies Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
750 Royal Oaks Drive, Suite 106, Monrovia, CA, USA, 91016
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.

Invizyne Technologies Headlines